Browsing publications by Professor Nicola Curtin

Newcastle AuthorsTitleYearFull text
Dr Tao Chen
Fiona Middleton
Professor Nicola Curtin
Development of pharmacodynamic biomarkers for ATR inhibitors2015
Liam Cornell
Dr Joanne Munck
Laura Ogle
Catherine Willoughby
Dr Despina Televantou
et al.
DNA-PK-A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival2015
Huw Thomas
Professor Nicola Curtin
Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself2015
Dr Miranda Patterson
Dr Ian Forrest
Becci Sharrock
Maria Lane
Dr Angelika Kaufmann
et al.
Assessing the function of homologous recombination DNA repair in malignant pleural effusion (MPE) samples2014
Wojciech Ciszewski
Dr Michele Tavecchio
Professor Nicola Curtin
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin2014
Dr Asima Mukhopadhyay
Michelle Dixon
Dr Evan Mulligan
James Murray
Professor Nicola Curtin
et al.
Evaluation of different methods to assess homologous recombination status and sensitivity to parp inhibitors in ovarian cancer2014
Professor Nicola Curtin
Dr Rakesh Heer
Investigating PARP-1 expression and activity in male and female, benign and malignant renal tissue2014
Fiona Middleton
Dr Tao Chen
Professor Nicola Curtin
p53 and other components of the DNA damage response as determinants of cell sensitivity to ATR inhibition2014
Professor Nicola Curtin
PARP inhibitors for anticancer therapy2014
Professor Nicola Curtin
PARP inhibitors target ATM+p53-defective gastric cancer2014
1234567891011121314151617181920...